Bristol Myers Squibb CEO describes new drug for treating schizophrenia
- Posted on January 13, 2025
- By CNBC
- 3 Views
Bristol Myers Squibb CEO describes new drug for treating schizophrenia
Bristol Myers Squibb CEO Chris Boerner described Cobenefy, a new drug to treat schizophrenia and may also help with bipolar disorder and Alzheimer's disease.
